S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)
S&P 500   5,096.27 (+0.52%)
DOW   38,996.39 (+0.12%)
QQQ   439.07 (+0.87%)
AAPL   180.74 (-0.37%)
MSFT   413.64 (+1.45%)
META   490.13 (+1.26%)
GOOGL   138.46 (+1.53%)
AMZN   176.76 (+2.08%)
TSLA   201.88 (-0.08%)
NVDA   791.12 (+1.87%)
NIO   5.75 (+5.89%)
AMD   192.53 (+9.06%)
BABA   74.03 (-0.75%)
T   16.93 (-0.18%)
F   12.44 (+1.14%)
MU   90.61 (+1.00%)
CGC   3.30 (-1.79%)
GE   156.89 (+0.82%)
DIS   111.58 (+0.70%)
AMC   4.32 (-13.43%)
PFE   26.56 (-1.78%)
PYPL   60.34 (+0.15%)
XOM   104.52 (+0.19%)

bioAffinity Technologies (BIAFW) SEC Filings & 10K Form

$0.19
-0.01 (-4.95%)
(As of 02/28/2024 ET)

Recent bioAffinity Technologies SEC Filings

DateFilerForm TypeView
02/02/2024
3:17 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Dougherty Michael Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:20 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
GIRGENTI STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/02/2024
3:21 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Rebel Vivienne I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Platt Jamie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Joyce Living Trust (Reporting)
Joyce Roby (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
Anderson Robert A. (Reporting)
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Meghji Mohsin Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
DIAMOND STUART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Zannes Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Harvey Sandler Revocable Trust (Reporting)
Rubin Gary D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
KNIGHT PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/24/2024
7:52 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
GIRGENTI STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/05/2023
7:45 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/30/2023
8:20 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/28/2023
3:00 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 424B5
11/27/2023
11:15 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form EFFECT
11/16/2023
4:23 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/14/2023
2:11 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/03/2023
3:45 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form S-8 POS
11/03/2023
3:49 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K/A
10/18/2023
4:10 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
10/10/2023
4:27 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/10/2023
5:03 AM
bioAffinity Technologies, Inc. (Subject)
bioAffinity Technologies (Subject)
Joyce Roby (Filed by)
Form SC 13G
09/26/2023
3:42 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Joyce Roby (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/25/2023
4:12 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Reveles Xavier Trinidad (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
09/22/2023
6:53 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form RW
09/20/2023
4:29 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form S-1
Registration statement under Securities Act of 1933  
09/20/2023
3:52 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/11/2023
3:00 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
GIRGENTI STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
KNIGHT PETER S (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Dougherty Michael Philip (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Zannes Maria (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Harvey Sandler Revocable Trust (Reporting)
Rubin Gary D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
GIRGENTI STEVEN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Meghji Mohsin Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
Anderson Robert A. (Reporting)
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2023
3:15 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
DIAMOND STUART (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2023
1:19 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2023
11:17 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/15/2023
11:22 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/11/2023
9:16 AM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Dougherty Michael Philip (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/01/2023
1:55 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form DEF 14A
05/01/2023
2:04 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/25/2023
9:03 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/19/2023
8:56 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form PRE 14A
04/19/2023
2:27 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
04/05/2023
11:28 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/31/2023
2:40 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2023
8:39 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/24/2023
2:49 PM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K/A
03/24/2023
7:01 AM
bioAffinity Technologies, Inc. (Filer)
bioAffinity Technologies (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/07/2023
6:50 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Perlmutter Nathan M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2023
6:42 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Meghji Mohsin Y (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
03/07/2023
6:44 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Meghji Mohsin Y (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2023
6:46 PM
bioAffinity Technologies, Inc. (Issuer)
bioAffinity Technologies (Issuer)
Perlmutter Nathan M (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:BIAFW) was last updated on 2/29/2024 by MarketBeat.com Staff